.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Argus Health
Farmers Insurance
Healthtrust
Teva
QuintilesIMS
Baxter
Queensland Health
Harvard Business School

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088911

« Back to Dashboard
NDA 088911 describes BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Hospira, Abraxis Pharm, and Fresenius Kabi Usa, and is included in three NDAs. It is available from six suppliers. Additional details are available on the BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

Summary for 088911

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 088911

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION 088911 ANDA Cardinal Health 55154-9395 55154-9395-8 1 VIAL, MULTI-DOSE in 1 BAG (55154-9395-8) > 10 mL in 1 VIAL, MULTI-DOSE
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION 088911 ANDA APP Pharmaceuticals, LLC 63323-924 63323-924-10 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-10) > 10 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength9MG/ML
Approval Date:Feb 7, 1985TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Colorcon
Harvard Business School
Covington
Cerilliant
Johnson and Johnson
Dow
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot